Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Homeodomain interacting protein kinase 2 (HIPK2); TAR DNA binding protein 43 (TDP-43; TARDBP)

June 16, 2016 7:00 AM UTC

In vitro and mouse studies suggest inhibiting HIPK2 could help treat ALS. In HEK cells and rat spinal motor neurons expressing a human ALS-associated TDP-43 mutation, an HIPK2 inhibitor tool compound ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article